桃红四物汤合五苓散抗静脉血栓的网络药理学研究

doi:10.3760/cma.j.issn.1007-1245.2023.18.022

国际医药卫生导报 ›› 2023, Vol. 29 ›› Issue (18): 2611-2616.DOI: 10.3760/cma.j.issn.1007-1245.2023.18.022

桃红四物汤合五苓散抗静脉血栓的网络药理学研究

宋洁菲周迎光

南京中医药大学连云港附属医院骨伤科，连云港　222004

收稿日期:2023-05-08 出版日期:2023-09-15 发布日期:2023-09-25
通讯作者: 周迎光，Email：47494535@qq.com
基金资助:
南京医科大学康达学院科研发展基金（KD2021KYYB2155）；连云港市卫生科技项目（202017）

Network pharmacology study on mechanism of Taohong Siwu decoction and Wuling powder in treatment of venous thromboembolism

Song Jiefei, Zhou Yingguang

Department of Orthopedics, Lianyungang Hospital Affiliated to Nanjing University of Chinese Medicine, Lianyungang 222004, China

Received:2023-05-08 Online:2023-09-15 Published:2023-09-25
Contact: Zhou Yingguang, Email: 47494535@qq.com
Supported by:
Scientific Research Foundation of Kangda College, Nanjing Medical University (KD2021KYYB2155); Lianyungang Health Science and Technology Project (202017)

摘要/Abstract

摘要：

目的　基于网络药理学和分子对接技术探讨桃红四物汤合五苓散抗静脉血栓生成的机制。方法　通过中药系统药理学数据库与分析平台（TCMSP）筛选桃红四物汤合五苓散的主要有效成分及作用靶点；通过Genecards、Gene和药物靶标数据库（TTD）筛选疾病相关靶点；使用Venny2.1.0平台获取药物和疾病共同靶点；使用STRING11.5数据库获取共同靶点蛋白相互作用（PPI）网络图；使用Metascape平台进行基因本体（GO）富集分析与京都基因和基因组百科全书（KEGG）富集分析；使用AutoDock软件进行分子对接。结果　得到药物有效成分103个、药物靶点213个、疾病靶点1 991个，共同靶点68个。主要的有效成分有槲皮素、山奈酚、木犀草素、β-谷甾醇、豆甾醇等，关键靶点有肿瘤坏死因子（TNF）、蛋白激酶B（AKT）1、白细胞介素（IL）1B、血管内皮生长因子（VEGF）A、基质金属蛋白酶9（MMP9）等。主要涉及的生物学过程和信号通路有细胞迁移的正调控、炎性反应、流体剪应力与动脉粥样硬化和血管VEGF信号通路等。结论　桃红四物汤合五苓散可能通过槲皮素、山奈酚、木犀草素等有效成分，调控磷脂酰肌醇3-激酶（PI3K）/蛋白激酶B（AKT）、诱导因子（HIF）-1α等信号通路，减少血管内皮损伤，抑制血小板聚集，抗静脉血栓形成。

关键词:

桃红四物汤, 五苓散, 静脉血栓栓塞症, 网络药理学, 分子对接, 作用机制

Abstract:

Objective　To explore the mechanism of Taohong Siwu decoction and Wuling powder in the treatment of venous thromboembolism based on network pharmacology and molecular docking technology. Methods　The main active components and targets of Taohong Siwu decoction and Wuling powder were screened through the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). The disease-related targets were screened through the Genecards Database, Gene Database, and Therapeutic Target Database. The shared targets of drugs and diseases were obtained by the Venny2.1.0. The PPI network maps of common target protein interactions were obtained by the STRING11.5 database. The gene ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were performed by the Metascape online platform. The AutoDock software was used for molecular docking. Results　One hundred and three active components, 213 drug targets, 1 991 disease targets, and 68 shared targets were obtained. The main active components include quercetin, Kaempferol, luteolin, β-sitosterol, and stigmasterol. The key targets are tumor necrosis factor (TNF), protein kinase B (AKT) 1, interleukin (IL) 1B, vascular endothelial growth factor (VEGF) A, matrix metalloproteinase 9 (MMP9), and so on. The biological processes and signaling pathways involved include positive regulation of cell migration, inflammatory response, fluid shear stress, arteriosclerosis, VEGF signaling pathway, etc. Conclusion　Taohong Siwu decoction and Wuling powder can prevent venous thrombosis and inhibit the injury of vascular endothelium and the aggregation of platelet by regulating Phosphatidylinositol 3-kinase (PI3K)/ Protein Kinase B(AKT), hypoxia inducible factor (HIF)-1α, and other signaling pathways through quercetin, kaempferol, luteolin, and so on.

Key words:

Taohong Siwu decoction, Wuling powder, Venous thromboembolism, Network pharmacology, Molecular docking, Mechanism

宋洁菲周迎光.

桃红四物汤合五苓散抗静脉血栓的网络药理学研究 [J]. 国际医药卫生导报, 2023, 29(18): 2611-2616.

Song Jiefei, Zhou Yingguang.

Network pharmacology study on mechanism of Taohong Siwu decoction and Wuling powder in treatment of venous thromboembolism [J]. International Medicine and Health Guidance News, 2023, 29(18): 2611-2616.

参考文献

[1] 上海市普通外科临床质量控制中心.上海市普通外科病人静脉血栓栓塞症防治管理规范(2020版)[J].中国实用外科杂志,2020,40(5):481-487.DOI:10.19538/j.cjps.issn1005- 2208.2020.05.01.
[2] 王有玲,周毅平.从"血不利则为水"论下肢深静脉血栓形成的治疗[J].中国中医基础医学杂志,2018,24(8):1170-1172. DOI:10.19945/j.cnki.issn.1006-3250.2018.08.050.
[3] 王玉兰,龚李萍,郭超峰.五苓散实验药理作用及临床应用研究进展[J].湖北中医药大学学报,2021,23(2):118-120.DOI:10.3969/j.issn.1008-987x.2021.02.34.
[4] 卢建华,沈淑劲,储小兵,等.活血利水法预防全膝置换术后下肢深静脉血栓的临床研究[J].中国中医骨伤科杂志,2022,30(2):31-35.
[5] 王紫艳,李磊,刘建勋,等.血瘀证血小板改变及中医药作用研究进展[J].中国中药杂志,2021,46(20):5201-5209.DOI:10.19540/j.cnki.cjcmm.20210629.701.
[6] Hopkins AL. Network pharmacology[J]. Nat Biotechnol, 2007,25(10):1110-1111. DOI: 10.1038/nbt1007-1110.
[7] 杨满英,陈雪珍,朱蓉,等.康艾注射液干预乳腺癌的网络药理学研究[J].中国中医药图书情报杂志,2022,46(1):6-13.DOI:10.3969/j.issn.2095-5707.2022.01.002.
[8] Gaillard T. Evaluation of autodock and autodock vina on the CASF-2013 benchmark[J]. J Chem Inf Model, 2018,58(8):1697-1706. DOI: 10.1021/acs.jcim.8b00312.
[9] 马炎,夏同霞,王安素,等.临床决策支持系统用于静脉血栓栓塞症预防管理的研究进展[J].护理学杂志,2022,37(17):107-109.DOI:10.3870/j.issn.1001-4152.2022.17.107.
[10] 严伟巍.外科手术患者预防静脉血栓栓塞症的研究进展[J].护理实践与研究,2022,19(18):2756-2761.DOI:10.3969/j.issn.1672-9676.2022.18.016.
[11] 田培裕,侯炜.癌症患者静脉血栓栓塞症的中西医预防进展[J].世界中医药,2022,17(17):2506-2511.DOI:10.3969/j.issn.1673-7202.2022.17.023.
[12] 刘国伦,赵迪,刘学芳,等.基于网络药理学和分子对接技术研究黄芪-赤芍治疗COPD的作用机制[J].世界科学技术-中医药现代化,2021,23(9):3132-3146.DOI:10.11842/wst.20210110002.
[13] 王雷,陈坤.基于网络药理学分析桃红四物汤治疗股骨头坏死的机制[J].实用临床医药杂志,2021,25(2):10-15,19.DOI:10.7619/jcmp.20200915.
[14] Gogoi D, Pal A, Chattopadhyay P, et al. First report of plant-derived β-sitosterol with antithrombotic, in vivo anticoagulant, and thrombus-preventing activities in a mouse model[J]. J Nat Prod, 2018,81(11):2521-2530. DOI: 10.1021/acs.jnatprod.8b00574.
[15] Chen T, Zhang X, Zhu G, et al. Quercetin inhibits TNF-α induced HUVECs apoptosis and inflammation via downregulating NF-kB and AP-1 signaling pathway in vitro[J]. Medicine (Baltimore), 2020,99(38):e22241. DOI: 10.1097/MD.0000000000022241.
[16] Cheng SC, Huang WC, S Pang JH, et al. Quercetin inhibits the production of IL-1β-induced inflammatory cytokines and chemokines in ARPE-19 cells via the MAPK and NF-κB signaling pathways[J]. Int J Mol Sci, 2019,20(12):2957. DOI: 10.3390/ijms20122957.
[17] 陈丹.山奈酚的抗炎镇痛作用及其机制研究[D].南京:南京中医药大学,2021.DOI:10.27253/d.cnki.gnjzu.2021. 000840.
[18] 王松松,黄慧珍,苏陈颖,等.基于网络药理学的山奈酚参与血府逐瘀汤治疗2型糖尿病作用机制研究[J].中国现代医生,2021,59(22):17-19,27.
[19] Fei J, Liang B, Jiang C, et al. Luteolin inhibits IL-1β-induced inﬂammation in rat chondrocytes and attenuates osteoarthritis progression in a rat model[J]. Biomed Pharmacother, 2019,109:1586-1592. DOI: 10.1016/j.biopha.2018.09.161.
[20] Zuo W, Liu N, Zeng Y, et al. Luteolin ameliorates experimental pulmonary arterial hypertension via suppressing hippo-YAP/PI3K/AKT signaling pathway[J]. Front Pharmacol, 2021,12:663551. DOI: 10.3389/fphar.2021.663551.
[21] 徐键,李乐,黄艳丽,等.炎症因子TNF-α、IL-6在慢性血栓栓塞性肺动脉高压患者中的表达及临床意义[J].昆明医科大学学报,2021,42(6):119-123.DOI:10.12259/j.issn. 2095-610X.S20210631.
[22] Iba T, Levy JH. Inflammation and thrombosis: roles of neutrophils, platelets and endothelial cells and their interactions in thrombus formation during sepsis[J]. J Thromb Haemost, 2018,16(2):231-241. DOI: 10.1111/jth.13911.
[23] 严志强,解绪红,冯凌思,等.膝关节置换术后早期外周血IL-1β、TNF-α水平对下肢深静脉血栓的预测价值[J].吉林医学,2022,43(3):602-605.DOI:10.3969/j.issn.1004-0412. 2022.03.008.
[24] 李达.TNF--α在深静脉血栓形成中的作用及其机制研究[D]. 苏州:苏州大学,2020. DOI:10.27351/d.cnki.gszhu.2020.003642.
[25] 黄博宁,林娟,彭思远,等.基于网络药理学探讨丹红化瘀口服液治疗深静脉血栓的作用机制[J].中草药,2022,53(6):1652-1662. DOI: 10.7501/j.issn.0253-2670.2022.06.007
[26] 刘晨,卞泗善,孔鹏,等.D-二聚体、P-选择素及血管内皮生长因子与下肢骨折患者深脉血栓形成的关系[J].现代生物医学进展,2021,21(15):2926-2930.DOI:10.13241/j.cnki.pmb.2021.15.026.
[27] Luo S, Li H, Mo Z, et al. Connectivity map identifies luteolin as a treatment option of ischemic stroke by inhibiting MMP9 and activation of the PI3K/Akt signaling pathway[J]. Exp Mol Med, 2019,51(3):1-11. DOI: 10.1038/s12276-019-0229-z.
[28] 娄秀娥,杨焕芝,李静.封闭负压引流技术联合针对性护理对糖尿病足溃疡区血管新生的影响[J].国际医药卫生导报,2021,27(6):920-924.DOI:10.3760/cma.j.issn.1007-1245. 2021.06.035.
[29] 章玉冰,李文,姚黎清,等.基质金属蛋白酶/金属蛋白酶组织抑制因子在大鼠创伤性深静脉血栓形成中的表达及作用[J].中国组织工程研究与临床康复,2010,14(11):2086-2090.DOI:10.3969/j.issn.1673-8225.2010.11.046.
[30] 周小涛.MMP-2、MMP-9在大鼠深静脉血栓形成过程的表达及意义的实验研究[D]. 南昌:南昌大学,2016.

桃红四物汤合五苓散抗静脉血栓的网络药理学研究

Network pharmacology study on mechanism of Taohong Siwu decoction and Wuling powder in treatment of venous thromboembolism

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 6

编辑推荐

Metrics

[1]	李静纯龙其雄冯峰孙伟. 基于网络药理学方法探讨黄芪-半枝莲抗结直肠癌的作用机制 [J]. 国际医药卫生导报, 2023, 29(19): 2737-2745..
[2]	刘治国, 崔文强, 魏叶, 朱心瑶, 杨雪. 基于计算机分子模拟技术从天然产物中筛选PPARγ激动剂[J]. 国际医药卫生导报, 2022, 28(9): 1204-1208.
[3]	唐琳琳, 李洪英, 刘文山, 丁传华. 人参皂苷Rg3抗肝癌作用研究进展[J]. 国际医药卫生导报, 2022, 28(7): 912-916.
[4]	苏昕妍, 金灿, 池永学. 精氨酸对肺损伤的保护效应及机制的进展[J]. 国际医药卫生导报, 2022, 28(4): 449-452.
[5]	任涛张开伟. 基于网络药理学探究筋痛灵膏外用治疗肩关节周围炎的作用机制[J]. 国际医药卫生导报, 2022, 28(19): 2665-2671.
[6]	杨世杰刘树杰曹芮闫玉荣. 艾司氯胺酮在剖宫产中的应用及研究进展[J]. 国际医药卫生导报, 2022, 28(13): 1919-1922.